(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

ANTIANDROGÊNIOS PARA O TRATAMENTO DE CÂNCER DE PRÓSTATA METASTÁTICO SENSÍVEL À CASTRAÇÃO

Em ExigênciaInvention PatentPCT · IB2020050752

Application data

Number

112021014969

Type

Invention Patent

Filing

01/30/2020

Publication

10/05/2021

PCT

IB2020050752

Progress at the INPI

Office action pending
  1. Filing01/30/20
  2. Publication10/05/21
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The INPI issued a technical office action on this application. If it is not answered in time, the application is abandoned (art. 36 of the Brazilian IP Act).

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 05/26/2026. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

ARAGON PHARMACEUTICALS, INC.

US

See this company's full portfolio

Inventors

M. Y. (pessoa física)

US

Technical data

Priority claims

US

62/798,836 · 01/30/2019

US

62/803,096 · 02/08/2019

US

62/822,312 · 03/22/2019

US

62/833,371 · 04/12/2019

US

62/836,920 · 04/22/2019

US

62/901,694 · 09/17/2019

Abstract

ANTIANDROGÊNIOS PARA O TRATAMENTO DE CÂNCER DE PRÓSTATA METASTÁTICO SENSÍVEL À CASTRAÇÃO.A presente invenção refere-se a métodos para tratar câncer de próstata metastático sensível à castração com antiandrogênios, incluindo, mas não se limitando a, 4-[7-(6-ciano-5-trifluorometilpiridin-3-il)-8-oxo-6-tioxo-5,7-diazaspiro[3,4]oct-5-il]-2-fluoro-N-metilbenzamida.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

6.9

Anulada a publicação código 6.23 na RPI nº 2888 de 12/05/2026 por ter sido indevida.

05/26/2026

RPI 2890

Parecer de pré-exame

#6.23

05/12/2026

RPI 2888

Notificação de entrada na fase nacional - PCT

#1.3

10/05/2021

RPI 2648

Alteração de dados cadastrais

#1.1

08/10/2021

RPI 2640

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.